Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy
Not Applicable
Completed
- Conditions
- FibroidMyomaLeiomyoma
- Interventions
- Device: SprayShield™
- First Posted Date
- 2009-05-01
- Last Posted Date
- 2017-09-07
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 15
- Registration Number
- NCT00891657
- Locations
- 🇩🇪
Pius Clinic, Oldenburg, Germany
Clinical Study of Safety and Efficacy for the Relieva Stratus With Elution of Triamcinolone Acetonide
Not Applicable
Completed
- Conditions
- Sinusitis
- Interventions
- Device: Stratus Microflow Ethmoid Spacer
- First Posted Date
- 2008-11-17
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 63
- Registration Number
- NCT00791934
- Locations
- 🇺🇸
Lahey Clinic, Burlington, Massachusetts, United States
PleuraSeal Pivotal Study (US)
Phase 3
Terminated
- Conditions
- Open Thoracotomy
- Interventions
- Device: PleuraSeal Sealant SystemProcedure: Standard Tissue Closure Techniques
- First Posted Date
- 2008-09-08
- Last Posted Date
- 2014-09-11
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 230
- Registration Number
- NCT00748124
- Locations
- 🇺🇸
Confluent Surgical, Bedford, Massachusetts, United States
DuraSeal Sealant Post Market Study
Not Applicable
Completed
- Conditions
- Elective Cranial Procedures With Dural Incision
- Interventions
- Device: DuraSeal Dural Sealant SystemOther: Standard of Care
- First Posted Date
- 2008-06-24
- Last Posted Date
- 2017-09-07
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 237
- Registration Number
- NCT00704340
- Locations
- 🇺🇸
Confluent Surgical, Waltham, Massachusetts, United States
PleuraSeal Post Market Study (Europe)
Phase 4
Completed
- Conditions
- Lung DiseasePulmonary Lobectomy
- Interventions
- Device: PleuraSeal Lung Sealant SystemProcedure: Standard Tissue Closure Techniques
- First Posted Date
- 2008-06-24
- Last Posted Date
- 2016-10-27
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 121
- Registration Number
- NCT00704171
- Locations
- 🇳🇱
Medical Centre Rotterdam Zuid, Rotterdam, Netherlands
🇨🇭University Hospital - Zurich, Zurich, Switzerland
🇺🇸Covidien, Bedford, Massachusetts, United States
Study to Evaluate Safety and Effectiveness of Spinal Sealant
Not Applicable
Completed
- Conditions
- Spinal Procedure Requiring Dura Incision
- Interventions
- Device: Spinal Sealant SystemDevice: Standard of care
- First Posted Date
- 2008-01-15
- Last Posted Date
- 2017-09-07
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 158
- Registration Number
- NCT00594035
- Locations
- 🇺🇸
Confluent Surgical, Inc., Bedford, Massachusetts, United States
Study to Evaluate Safety & Effectiveness of Spinal Sealant
Not Applicable
Completed
- Conditions
- Cerebrospinal Fluid Leakage, Subdural
- Interventions
- Device: Spinal SealantOther: Standard of Care
- First Posted Date
- 2007-03-07
- Last Posted Date
- 2017-09-07
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 98
- Registration Number
- NCT00444067
- Locations
- 🇺🇸
Confluent Surgical, Inc., Bedford, Massachusetts, United States
Study to Evaluate Safety & Effectiveness of Vascular Sealant System
Not Applicable
Terminated
- Conditions
- Peripheral Vascular Disease
- Interventions
- Device: Gelfoam/ThrombinDevice: VascuSeal
- First Posted Date
- 2007-02-23
- Last Posted Date
- 2017-09-07
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 69
- Registration Number
- NCT00439309
- Locations
- 🇺🇸
Confluent Surgical, Inc., Waltham, Massachusetts, United States
DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery
Not Applicable
Terminated
- Conditions
- Spinal InjuriesAdhesions
- Interventions
- Device: DuraGen Plus Adhesion Barrier Matrix
- First Posted Date
- 2006-10-13
- Last Posted Date
- 2017-09-07
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 347
- Registration Number
- NCT00387829
- Locations
- 🇺🇸
Tallahassee Neurological Clinic, Tallahassee, Florida, United States
🇺🇸Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸Orthopedics Intl., Seattle, Washington, United States
Clinical Evaluation to Confirm Safety and Efficacy of Sinuplasty in the Paranasal Sinuses (CLEAR)
Phase 3
Completed
- Conditions
- Chronic Sinusitis
- First Posted Date
- 2005-10-04
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 115
- Registration Number
- NCT00231062
© Copyright 2025. All Rights Reserved by MedPath